Ok, Histonetters I have another question for you.
According the CAP checklist question:
ANP.22750 Phase II
Has the laboratory documented evaluation of new antibody lots and new
antibodies, prior to use in patient diagnosis?
NOTE: For newly introduced antibodies, staining conditions should be
evaluated in cases expected to be positive and negative for the antigen
of interest. Ideally, a series of sufficient size should be run to give
the laboratory an idea of the sensitivity and specificity of the test.
How are you folks handling this question when using Ventana?
Thanks a bunch.
Sharon Davis-Devine, CT (ASCP)
602 West University
Urbana, Illinois 61801
Histonet mailing list